Business
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
$200 million repurchase program authorized to repurchase common stock and/or convertible notesRepurchasing approximately $160 million of 0.75% Senior Notes
About this update from Cryoport, Inc.
[{"type":"text","content":"$200 million repurchase program authorized to repurchase common stock and/or convertible notesRepurchasing approximately $160 million of 0.75% Senior Notes due in 2026 at an 11.5% discount to par valuePrincipal balance reduced to approximately $186.2 millionNASHVILLE, Tenn., Aug. 6, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) (\"Cryoport\" or the \"Company\"), a global leader in supply chain solutions for the life sciences, today announced that the Company's Board of Directors had authorized a repurchase program to purchase up to $200 million of the Company's common stock and/or convertible senior notes (the \"2024 Repurchase Program\"). The 2024 Repurchase Program became effective on August 1, 2024 and remains in effect through December 31, 2027. \n\n \n \n \n \n \n \n\n \nThe Company also announced that it has entered into agreements with certain holders of its 0.75% Convertible Senior Notes due in 2026 (the \"2026 Notes\") to repurchase $160 million in aggregate principal amount of the 2026 Notes (the \"Transactions\") for an aggregate repurchase price of $141.6 million, plus accrued and unpaid interest. The Transactions were made under the 2024 Repurchase Program.\nJerrell Shelton, CEO of Cryoport, commented, \"We are pleased to complete this opportunistic repurchase of our 2026 Notes. With our strong cash position, we are in a position to reduce our outstanding debt and further strengthen our balance sheet, while also maintaining considerable liquidity to support our long-term growth plans.\"\nThe Transactions are expected to close on August 9, 2024, subject to the satisfaction of customary closing conditions. Following such closings, approximately $186.2 million principal amount of the 2026 Notes will remain outstanding, from an initial issued principal balance of $402.5 million.\nThis press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any offer or sale of these securities in any state or jurisdiction in which the offer, solicitation, or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.\nAbout Cryoport, IncCryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enable...